Bell Investment Advisors, Inc

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1890149 ORINDA, CA

Position in RDY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$14,562

-$9,315 QoQ

Shares Held

1,005

-41.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#201

of 238 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bell Investment Advisors, Inc holds $111,986 across 20 Drug Manufacturers - Specialty & Generic names. RDY ranks #2 (13.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	41	$22,215
2	RDY	Dr Reddys Laboratories Ltd This page	1,005	$14,562
3	HCM	HUTCHMED (China) Ltd	1,015	$10,921
4	TAK	Takeda Pharmaceutical Co Ltd	488	$7,822
5	VTRS	Viatris Inc	454	$7,209
6	NBIX	Neurocrine Biosciences Inc	41	$6,910
7	ZTS	Zoetis Inc.	94	$6,754
8	ELAN	Elanco Animal Health Inc	264	$6,497

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,562	1,005	-41.7%	Shares	Sole	2026-08-07
2026-03-31	$23,877	1,724	-6.5%	Shares	Sole	2026-04-17
2025-12-31	$25,875	1,843	+88.1%	Shares	Sole	2026-02-24
2025-09-30	$13,700	980	+5.9%	Shares	Sole	2025-11-21
2025-06-30	$13,902	925	+224.6%	Shares	Sole	2025-08-11
2025-03-31	$3,759	285	-56.0%	Shares	Sole	2025-05-16
2024-12-31	$10,216	647	+352.4%	Shares	Sole	2025-02-07
2024-09-30	$11,361	143	0.0%	Shares	Sole	2024-11-13
2024-06-30	$10,895	143	+18.2%	Shares	Sole	2024-08-08
2024-03-31	$8,875	121	+92.1%	Shares	Sole	2024-05-08
2023-12-31	$4,383	63	+12.5%	Shares	Sole	2024-02-14
2023-09-30	$3,744	56	+93.1%	Shares	Sole	2023-11-08
2023-06-30	$1,830	29	+190.0%	Shares	Sole	2023-08-09
2023-03-31	$569	10	-50.0%	Shares	Sole	2023-05-10
2022-12-31	$1,035	20	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.